Product Information

ERYTHROMYCIN 0.5% EYE OINTMENT is a generic product labeled by ARMAS PHARMACEUTICALS INC., priced at $6.8670 per GM under NDC 72485067031. Its NADAC has been published 124 times since Jul 3, 2024.

FDA first approved this application on Jul 18, 1996. Its Orange Book therapeutic-equivalence code is AT.

ERYTHROMYCIN 0.5% EYE OINTMENT

Erythromycin
$6.8670per GM

Strength

5 mg/g

NDC

72485067031

Classification

Generic

Dosage Form

OINTMENT

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA064030

FDA Approved

7/18/1996

TE Code

AT

On Market Since

10/18/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has been published 124 times since Jul 3, 2024, and over the history we have for it it has risen 97.3%. The table below summarizes its recorded NADAC range and movement.

Current price$6.8670 per GM
All-time high$7.6426 (Sep 10, 2025)
All-time low$3.4370 (Jul 17, 2024)
52-week high$6.8670
52-week low$6.1653
Median price$6.3254
Average price$5.8607
Largest weekly change+23.4% (Jan 22, 2025)
Weeks tracked124
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

+0.5%

3M

+8.6%

6M

+8.6%

1Y

-1.5%

3Y

N/A

5Y

N/A

All

+97.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN 0.5% EYE OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 0.5% EYE OINTMENT, manufactured by ARMAS PHARMACEUTICALS INC., is $6.8670 per GM (NDC 72485067031), effective Nov 11, 2026.

How has the price of ERYTHROMYCIN 0.5% EYE OINTMENT changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has risen 97.3%. It has been tracked across 124 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 0.5% EYE OINTMENT?

Since Jul 3, 2024, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has ranged from a low of $3.4370 (Jul 17, 2024) to a high of $7.6426 (Sep 10, 2025), with a median of $6.3254 per GM.

Are there cheaper alternatives to ERYTHROMYCIN 0.5% EYE OINTMENT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 0.5% EYE OINTMENT, is $2.7996 per GM — about 59% below ERYTHROMYCIN 0.5% EYE OINTMENT.

Who manufactures ERYTHROMYCIN 0.5% EYE OINTMENT?

ERYTHROMYCIN 0.5% EYE OINTMENT (NDC 72485067031) is labeled by ARMAS PHARMACEUTICALS INC., and CMS classifies it as a generic product.